Day-to-day research results on the COVID-19 situation in hospitals, based on our own COVID-19 registry.Read more
Your team is always there for you
You can do clinical research alongside your day-to-day clinical work.
Your project starts
We work with you to produce all the relevant documentation that needs to be submitted for the required testing procedures.
We support you and, if you wish, we can manage your communications with ethics committees and the relevant national competent authority (e.g. BfArM in Germany) for you.
Your team is ready
Your team brings together specialists who have a thorough understanding of the details and generalists who are good at keeping an eye on the big picture.
Your team combines lots of talent, experience and knowledge. When everyone works together, the study will be a success.
Everything under control
Our project managers guide your study for you. They manage your research every day. They maintain an overview of the big picture and notice any unexpected events. Even when everything has been carefully planned, things doesn’t always go according to plan. Your team will be prompt and flexible in discussing the measures that are necessary to get your study back on track with you.
You will receive status reports from us and interim results that document the successful progress of your study.
Clinics - the pillars of your research
We maintain contact with the study centres for the entire duration of your study. We take care of the contracts, remuneration and all the formalities.
We monitor patient inclusion, chase things up and provide that bit of encouragement if the number of participants is lower than expected.
Our monitors are there for you at the study centres. They train the staff at the study centres and help the study assistants to gain an understanding of the specific requirements of your study. They make the centres aware of the details of your study and the quality of your data.
Patients are the key to success
Up to five years after inclusion, we telephone patients to collect data for your study and provide you with information about the long-term success of a treatment.
At 95 per cent, our follow-up rate is far above average. Our patient service employees are helpful to the patients. They ask the patients questions in an empathetic and precise manner and this allows them to obtain results for long-term observation within the scope of your study.
Steering Committee meetings
CEC Clinical Events Committee
Monte Carlo simulations
Project Management Plan (PMP)
Safety Management Plans
Presentation of the second evaluation of the COVID-19 registry for Rhineland-Palatinate by Dr. Anselm K. Gitt, board of directors of Foundation Institute for Myocardial Infarction Research in and study director of the COVID-19 registry...Read more
Dr Anselm K. Gitt, board member of the IHF, reports on his current research results on the COVID-19 situation in hospitals in a video conference hosted by Torbjörn Kartes, member of the German BundestagRead more